Modernaits personalised cancer vaccine program succeeded in a mid-stage study of skin cancer patients, affirming that its messenger RNA technology can be a game-changer beyond Covid-19 vaccines. Investors were delighted by the news, sending Moderna's stock price up 21% by midday Tuesday.
"It's, for me, a Covid-like moment going back to January 2020," he said to Insider."It's the same thing for me. The enemy now is cancer. We know the technology works." Bancel said Moderna's mRNA approach is the key to its success. Moderna uses mRNA to get inside of immune cells and instruct those cells to produce particular proteins that can help fight that person's cancer.
"Now, we are an oncology company," Bancel said,"and we might be one of the biggest oncology companies down the road." However these trials will likely take years to finish, Bancel acknowledged, meaning potential FDA approval and commercial launch is The biotech company Moderna just announced a significant advance in its efforts to treat cancer, which could represent a major breakthrough in treating the disease several years out.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BISouthAfrica - 🏆 34. / 51 Read more »